← All companies
Amneal Pharmaceuticals, Inc.
AMRX - CIK 0001723128
Market cap$4.89 B
Rank#1397
SEC filings664
The table below shows Amneal Pharmaceuticals, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $282.03M | $110.55M | $91.54M | $25.98M | $247.79M | $341.38M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | $741.79M | $662.58M | $638.89M |
| Inventory | $606.30M | $612.45M | $581.38M | $530.74M | $489.39M | $490.65M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.